New cancer clinical trial: A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer

Published on: December 03, 2018 at 12:00PM
Condition:   Bladder Cancer
Intervention:   Drug: TAS 102
Sponsors:   Rahul Parikh;   Taiho Oncology, Inc.
Not yet recruiting
https://ift.tt/2QvkbIB